Leàn Rolfes
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 17
- Pharmacovigilance and Adverse Drug Reactions 17
-
- Pharmaceutical Practices and Patient Outcomes 3
- Co-authors
- Eugène van Puijenbroek (13 shared papers)Florence van Hunsel (12 shared papers)Katja Taxis (3 shared papers)Kees van Grootheest (3 shared papers)Linda Härmark (6 shared papers)Tim Schutte (2 shared papers)Gurumurthy Parthasarathi (1 shared paper)Daisuke Tanaka (1 shared paper)
- Journals
- Drug Safety (5 papers)Expert Opinion on Drug Safety (4 papers)Pharmacoepidemiology and Drug Safety (3 papers)British Journal of Clinical Pharmacology (2 papers)Vaccine (2 papers)
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
Leàn Rolfes
22 papers receiving 408 citations
Peers
Comparison fields: 5 of 70
- Toxicology 272
- Geriatrics and Gerontology 34
- Pharmacology 28
- Pharmacology 42
- Safety Research 22
Countries citing papers authored by Leàn Rolfes
This map shows the geographic impact of Leàn Rolfes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leàn Rolfes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leàn Rolfes more than expected).
Fields of papers citing papers by Leàn Rolfes
This network shows the impact of papers produced by Leàn Rolfes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leàn Rolfes. The network helps show where Leàn Rolfes may publish in the future.
Co-authors
The 23 scholars most cited alongside Leàn Rolfes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 70 | |
| 2 | 2014 | 64 | |
| 3 | 2018 | 54 | |
| 4 | 2016 | 49 | |
| 5 | 2017 | 29 | |
| 6 | 2013 | 24 | |
| 7 | 2022 | 22 | |
| 8 | 2019 | 17 | |
| 9 | 2017 | 15 | |
| 10 | 2018 | 14 | |
| 11 | 2016 | 11 | |
| 12 | 2015 | 10 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 2018 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2019 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2019 | 2 |
About Leàn Rolfes
Leàn Rolfes is a scholar working on Toxicology, Geriatrics and Gerontology, Pharmacology, Economics and Econometrics and Infectious Diseases, having authored 23 papers that have together received 417 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (17 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Poisoning and overdose treatments (1 paper), Cannabis and Cannabinoid Research (1 paper), Drug-Induced Adverse Reactions (1 paper) and Substance Abuse Treatment and Outcomes (1 paper). The work is most often cited by research in Toxicology (272 citations), Geriatrics and Gerontology (34 citations), Pharmacology (28 citations), Pharmacology (42 citations) and Safety Research (22 citations). Leàn Rolfes has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Eugène van Puijenbroek, Florence van Hunsel, Katja Taxis, Kees van Grootheest, Linda Härmark, Tim Schutte, Gurumurthy Parthasarathi, Daisuke Tanaka, Andries S. Koster and Lara Magro. Their work appears in journals such as Drug Safety, Expert Opinion on Drug Safety, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.